<p>Anoro Ellipta is a medicine used to relieve the symptoms of chronic obstructive pulmonary disease (COPD) in adults. COPD is a long-term disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty breathing. Anoro Ellipta is used for maintenance (regular) treatment.<br>Anoro Ellipta contains the active substances umeclidinium bromide and vilanterol.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Anoro Ellipta is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).</p> </div>
Therapeutic Area (MeSH)
ATC Code
R03AL03
ATC Item
N/A
Pharmacotherapeutic Group
Drugs for obstructive airway diseases
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| umeclidinium bromide | N/A | umeclidinium bromide |
| vilanterol trifenatate | N/A | vilanterol trifenatate |
EMA Name
Anoro Ellipta (previously Anoro)
Medicine Name
Anoro Ellipta (previously Anoro)
Aliases
N/ANo risk management plan link.
